Drugabilis supports early R&D projects by fast and rationally developing early formulations for in vivo studies (efficacy, PK, Tox) in any species, optimizing the crystal form of new drug candidates and characterizing the physicochemical profiles of research compounds.
With an experience of about 20 years and 250+ clients, Drugabilis contributes to a faster selection of robust “drugs candidates” that will be able to fast undergo regulatory preclinical development phases to reach clinical trials